CMPS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
CMPS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Compass Pathways's yield on cost for the quarter that ended in Dec. 2024 was 0.00.
The historical rank and industry rank for Compass Pathways's 5-Year Yield-on-Cost % or its related term are showing as below:
For the Medical Care Facilities subindustry, Compass Pathways's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, Compass Pathways's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Compass Pathways's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Therefore, Yield-on-Cost of Compass Pathways is calculated as
Yield-on-Cost | = | Dividend Yield % | * | (1 | + | Dividend Growth Rate)^5 |
Compass Pathways (NAS:CMPS) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Thank you for viewing the detailed overview of Compass Pathways's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.
Atai Life Sciences N.v. | 10 percent owner | 524 BROADWAY, NEW YORK NY 10013 |
Ekaterina Malievskaia | officer: Chief Innovation Officer | C/O COMPASS PATHWAYS PLC, 3RD FLOOR, 1 ASHLEY ROAD, ALTRINCHAM, CHESHIRE X0 WA14 2DT |
George Jay Goldsmith | director, 10 percent owner, officer: Chief Executive Officer | C/O COMPASS PATHWAYS PLC, 1 ASHLEY ROAD, 3RD FLOOR, ALTRINCHAM, CHESHIRE X0 WA14 2DT |
Mary-rose Hughes | officer: Interim CFO | C/O COMPASS PATHWAYS PLC, 33 BROADWICK STREET, LONDON X0 W1F0DQ |
Daphne Karydas | director | 35 GATEHOUSE DRIVE, BUILDING D, FLOOR 3, WALTHAM MA 02451 |
Kabir Nath | director, officer: Chief Executive Officer | C/O COMPASS PATHWAYS PLC, 33 BROADWICK STREET, LONDON X0 W1F 0DQ |
Annalisa Jenkins | director | C/O ARDELYX, INC., 34715 ARDENWOOD BLVD, SUITE 100, FREMONT CA 94555 |
David Y Norton | director | 8 GREENHOLM STREET, APT C, PRINCETON NJ 08540 |
Matthew A Owens | officer: General Counsel & CLO | 1900 POLARIS PARKWAY, COLUMBUS OH 43240 |
Atai Life Sciences Ag | 10 percent owner | KRAUSENSTRASSE 9-10, BERLIN 2M 10117 |
Linda Mcgoldrick | director | C/O AVADIM HEALTH, INC., 81 THOMPSON STREET, ASHEVILLE NC 28803 |
Jason Camm | director | C/O ATAI LIFE SCIENCES N.V., 180 VARICK STREET, NEW YORK NY 10014 |
Robert Mcquade | director | C/O COMPASS PATHWAYS PLC, 3RD FLOOR, 1 ASHLEY ROAD, ALTRINCHAM, CHESHIRE X0 WA14 2DT |
Michael Falvey | officer: Chief Financial Officer | C/O KARYOPHARM THERAPEUTICS INC., 85 WELLS AVENUE, 2ND FLOOR, NEWTON MA 02459 |
Guy Goodwin | officer: Chief Medical Officer | C/O COMPASS PATHWAYS PLC, 3RD FLOOR, 1 ASHLEY ROAD, ALTRINCHAM, CHESHIRE X0 WA14 2DT |
From GuruFocus
By GlobeNewswire • 05-03-2024
By Business Wire • 02-18-2025
By Marketwired • 08-01-2024
By GuruFocus News • 02-28-2025
By Business Wire • 01-21-2025
By GuruFocus News • 11-15-2024
By Business Wire • 10-24-2024
By Marketwired • 06-26-2024
By Business Wire • 02-27-2025
By Business Wire • 09-23-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.